Virbac Xylazine 100

国: ニュージーランド

言語: 英語

ソース: Ministry for Primary Industries

有効成分:

xylazine present as xylazine hydrochloride

から入手可能:

Virbac New Zealand Limited

INN（国際名）:

xylazine

構図:

xylazine present as xylazine hydrochloride 100 g/litre

治療領域:

Analgesic

認証ステータス:

ACVM Registered

承認日:

1991-10-09

製品の特徴

Virbac Xylazine 100
January 2021
VIAL AND CONTAINER LABEL
Left panel
STERILE INJECTION.
KEEP OUT OF REACH OF CHILDREN
RESTRICTED VETERINARY MEDICINE
Virbac Xylazine 100
Registered pursuant to the ACVM Act 1997, No. A6301.
WITHHOLDING PERIODS
Meat: Animals producing meat or offal for human consumption must not
be sold for slaughter either
during treatment or within 3 days of the last treatment.
Milk: Milk intended for sale for human consumption must be discarded
during treatment and for not less
than 14 milkings or approximately 168 hours following the last
treatment.
Registered to and manufactured in New Zealand by:
VIRBAC NEW ZEALAND LIMITED
26 – 30 Maui St, Pukete, Hamilton.
Centre panel
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
Virbac Xylazine 100
Xylazine (as hydrochloride) 100 mg/ml
NET VOLUME: 50mL
Right panel
INDICATIONS: A sedative with analgesic, pre-anaesthetic and muscle
relaxant properties for use in
cattle, horses, sheep, deer and goats.
CONTRAINDICATIONS: Treatment during the last month of pregnancy;
cardiovascular or cardiac disease
or where hypertension may already exist; conditions where respiratory
depression already exists; in
alimentary obstruction.
DOSE RATES: See product leaflet.
Batch no:
Expiry:
Virbac Xylazine 100
January 2021
LEAFLET
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
Virbac Xylazine 100
Sedative, analgesic and muscle relaxant for cattle, horses, sheep,
goats and deer.
Xylazine (2(2,6-dimethylphenylamino) - 4H – 5,6 – dihydro – 1,3
– thiazine hydrochloride) is a sedative
with variable analgesic and muscle relaxant properties. Its sedative
effect is several times greater in
ruminants than in other domestic species, and it is thought to exert
its major effect on presynaptic alpha
2-adrenoceptors.
Xylazine acts centrally to cause muscle relaxation.
The degree of analgesia following the use of xylazine is variable and
dose-related. The concomitant use
of an appropriate anaesthetic agent is recommended for painful
procedures.
Following intramuscu